Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (8,772,866)	$ (6,876,432)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	14,180	22,205
Amortization of intangibles	49,663	51,630
Stock based compensation	1,499,302	790,915
Employees paid in stock	317,265	793,110
Expense paid in stock	747,351	707,861
Inventory Reserve	582,299	0
Amortization of right-of-use asset	80,533	73,552
Gain on debt extinguishment-PPP	0	(276,180)
Deferred profit and divesture-equity investment (See Note F)	0	(242,589)
Changes in operating assets and liabilities:
Decrease in accounts receivable	249,555	137,384
(Increase) decrease in inventories	(833,121)	878,666
(Increase) in advances on contracts	(16,041)	(895,058)
(Increase) decrease in prepaid expenses and other current assets	(68,512)	40,555
Increase in accounts payable	322,300	297,456
Increase in accounts payable, related party	407,636	10,719
(Decrease) increase in accrued expenses	(292,495)	562,824
(Decrease) in accrued expenses, related party	(246,692)	(47,493)
Decrease operating lease liability	(72,353)	(62,789)
Net cash used in operating activities	(6,031,996)	(4,033,664)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(8,527)	(15,189)
Net cash used in investing activities	(8,527)	(15,189)
Cash flows from financing activities:
Payments finance lease obligations	(8,544)	(8,648)
Proceeds from exercise of warrants	0	3,216,044
Common stock issued to employee for option exercised	0	1,381,886
Net cash used in (provided by) financing activities	(8,544)	4,589,282
Net (decrease) increase in cash and cash equivalents	(6,049,067)	540,429
Cash and cash equivalents at beginning of period	14,764,346	14,223,917
Cash and cash equivalents at end of period	$ 8,715,279	$ 14,764,346